GNPX — Genprex Balance Sheet
0.000.00%
- $7.00m
- $5.40m
Annual balance sheet for Genprex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 27.3 | 38.6 | 21 | 6.74 | 1.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0 | 0 | 0.035 | 0 | — |
Prepaid Expenses | |||||
Total Current Assets | 27.7 | 39.1 | 21.5 | 7.53 | 2.08 |
Net Property, Plant And Equipment | 0.039 | 0.049 | 0.023 | 0.008 | 0 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 31.4 | 42.9 | 25.1 | 10.7 | 4.12 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.451 | 1.59 | 2.81 | 3.25 | 2.5 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.451 | 1.59 | 2.81 | 3.25 | 2.5 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 30.9 | 41.3 | 22.3 | 7.42 | 1.62 |
Total Liabilities & Shareholders' Equity | 31.4 | 42.9 | 25.1 | 10.7 | 4.12 |
Total Common Shares Outstanding |